|
Showing 1 - 2 of
2 matches in All Departments
Among malignant tumors, adenocarcinomas of the esophagogastric
junction show the highest increase in incidence over the past three
decades in Western industrialized countries. This special volume,
with contributions from experts in the field, covers all aspects of
the disease. Etiology, pathogenesis, classification, and clinical
staging are discussed, and there is special emphasis on state of
the art treatment techniques. The latter range from endoscopic
mucosal resections or limited surgical resections for early cancers
to multimodality treatment options for locally advanced tumors.
Emerging quality issues in surgical management are addressed.
Detailed attention is also paid to other important recent
developments, including molecular response prediction, early
metabolic response evaluation by PET and PET-CT, the diagnosis of
micrometastases, and the use of sentinel node technology. This
volume will be of interest to all clinicians concerned with the
diagnosis and management of this malignancy.
Among malignant tumors, adenocarcinomas of the esophagogastric
junction show the highest increase in incidence over the past three
decades in Western industrialized countries. This special volume,
with contributions from experts in the field, covers all aspects of
the disease. Etiology, pathogenesis, classification, and clinical
staging are discussed, and there is special emphasis on state of
the art treatment techniques. The latter range from endoscopic
mucosal resections or limited surgical resections for early cancers
to multimodality treatment options for locally advanced tumors.
Emerging quality issues in surgical management are addressed.
Detailed attention is also paid to other important recent
developments, including molecular response prediction, early
metabolic response evaluation by PET and PET-CT, the diagnosis of
micrometastases, and the use of sentinel node technology. This
volume will be of interest to all clinicians concerned with the
diagnosis and management of this malignancy.
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.